Walvax Biotechnology Co., Ltd.
SZSE:300142.SZ
23.35 (CNY) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Walvax Biotechnology Co., Ltd. |
Symbool | 300142.SZ |
Munteenheid | CNY |
Prijs | 21.88 |
Beurswaarde | 35,168,818,350 |
Dividendpercentage | 0% |
52-weken bereik | 21.18 - 47.88 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Runsheng Jiang |
Website | https://www.walvax.com |
An error occurred while fetching data.
Over Walvax Biotechnology Co., Ltd.
Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, researches and develops, produces, and sells bio-medicine products in China. The company offers biomedicines, such as vaccines, blood products, and others. It provides Group A, C meningococcal polysaccharide conjugate vaccine for infants below or equal to 2 years preventing diseases, such as
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)